Trials / Conditions / Childhood B Acute Lymphoblastic Leukemia

Childhood B Acute Lymphoblastic Leukemia

7 registered clinical trials studyying Childhood B Acute Lymphoblastic Leukemia.

Status	Trial	Sponsor	Phase
Completed	Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating You NCT01403415	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic NCT01190930	Children's Oncology Group	Phase 3
Completed	Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Ly NCT00866307	Children's Oncology Group	Phase 1
Completed	Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagno NCT00671034	Children's Oncology Group	Phase 3
Completed	Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia NCT00437060	Children's Oncology Group	—
Completed	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00103285	Children's Oncology Group	Phase 3
Completed	Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin Du NCT00075725	Children's Oncology Group	Phase 3